Drug Shortage Report for PMS-ABACAVIR-LAMIVUDINE

Last updated on 2022-06-23 History
Report ID 77526
Drug Identification Number 02458381
Brand name PMS-ABACAVIR-LAMIVUDINE
Common or Proper name ABACAVIR/LAMIVUDINE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) ABACAVIR LAMIVUDINE
Strength(s) 600MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2019-03-01
Estimated end date 2022-04-25
Actual end date 2022-06-22
Shortage status Resolved
Updated date 2022-06-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2022-06-23 French Compare
v18 2022-06-23 English Compare
v17 2021-11-17 French Compare
v16 2021-11-17 English Compare
v15 2021-06-18 French Compare
v14 2021-06-18 English Compare
v13 2021-06-18 English Compare
v12 2020-07-07 French Compare
v11 2020-07-07 English Compare
v10 2020-03-10 French Compare
v9 2020-03-10 English Compare
v8 2019-12-24 French Compare
v7 2019-12-24 English Compare
v6 2019-09-12 French Compare
v5 2019-09-12 English Compare
v4 2019-05-09 French Compare
v3 2019-05-09 English Compare
v2 2019-03-04 French Compare
v1 2019-03-04 English Compare

Showing 1 to 19 of 19